Deciphering a cell death-associated signature for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma

BACKGROUND: Lung squamous cell carcinoma (LUSC) is a subtype of non-small cell carcinoma, accounting for about 30% of all lung cancers. Yet, the evaluation of prognostic outcome and therapy response of patients with LUSC remains to be resolved. This study aimed to explore the prognostic value of cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mao, Guangxian, Yang, Dongyong, Liu, Bin, Zhang, Yu, Ma, Sijia, Dai, Shang, Wang, Guoqiang, Tang, Wenxiang, Lu, Huafei, Cai, Shangli, Zhu, Jialiang, Yang, Huaping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324233/
https://www.ncbi.nlm.nih.gov/pubmed/37415224
http://dx.doi.org/10.1186/s12931-023-02402-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324233/
https://www.ncbi.nlm.nih.gov/pubmed/37415224
http://dx.doi.org/10.1186/s12931-023-02402-9

Ejemplares similares